Euretos

Euretos AI Platform - Data-Driven disease insight for disease research, target discovery, and indication selection.

[Euretos @Euretos]

Studies highlight the interplay of genetics and environmental factors in Parkinson's disease risk. Our platform aids researchers in understanding these relationships to devise prevention strategies. Free access for academics: https://t.co/6lPIa68Xns #PD #translationalResearch

[Euretos @Euretos]

Recent genomic studies reveal lncRNAs as pivotal in Parkinson's disease, offering early diagnosis & personalized treatments. Our AI research platform aids in analysiing these RNA sequences for therapy development. https://t.co/vmcoB3VFgp #ParkinsonsDisease #PrecisionMedicine

[Euretos @Euretos]

Recent study in Nature Neuroscience reveals distinct dopaminergic neuron types in the human brain, some highly vulnerable to Parkinson's. Discovery via RNA sequencing could lead to targeted PD therapies. #ParkinsonsDisease #Neuroscience #EuretosPlatform

[Euretos @Euretos]

Analyzing the impact of a pivotal 2015 review on Parkinson's by Kalia & Lang, which shaped PD research with 2000+ citations. Its visualization on a citation chart reflects its foundational role and enduring influence in high-impact journals. #ResearchImpact #ParkinsonsDisease

[Euretos @Euretos]

April is Parkinson's Disease Awareness Month, spotlighting the challenges and research progress for PD. It’s a call to educate, support patients, and push for translational research. Let’s unite for a future where Parkinson's is a challenge of the past. #ParkinsonsResearch

[Euretos @Euretos]

Advancing DMD research: Signorelli et al.'s study, supported by Euretos, showcases biological profiling's power to unravel disease complexities via multi-omics, spotlighting novel biomarkers and therapy paths. #BiologicalProfiling #DMDResearch

[Euretos @Euretos]

Unraveling PKD with our platform: Dive into metabolic PPI networks & discover how vasopressin's role impacts PKD progression. Explore data-rich insights & evidence-based relations for biomarker discovery & therapeutic solutions. Free access for academics! #BiomarkerDiscovery

[Euretos @Euretos]

Chronic Kidney Disease (CKD) affects millions globally, with prevalence rising in older adults due to factors like aging and hypertension. Research into precise clinical markers like eGFR is crucial for advancing CKD treatment and improving life quality. #CKDResearch

[Euretos @Euretos]

Euretos Platform enables drug discovery by integrating vast datasets for translational research, supporting the discovery of molecules and antibodies to modulate targets effectively. Accelerate target assessment and streamline discovery with AI insights. #translationalresearch

[Euretos @Euretos]

Biological profiling via enrichment analysis of genes linked to diseases like PKD reveals key biological processes and pathways, offering insights into disease mechanisms and progression. https://t.co/22d2OI0vt7

[Euretos @Euretos]

A recent Nature paper provides a kidney cellular atlas, with 400,000+ cells analyzed, uncovering 51 cell types and 28 altered states in injury. Our AI platform provides access to this pivotal article but also to related single-cell expression data and similar articles.

[Euretos @Euretos]

This #KidneyMonth, dive into target discovery with us. Explore advanced multi-omics for kidney diseases, refine by gene expression, and identify therapeutic targets. Leverage our tools for improving kidney health. Academic researchers get free access. https://t.co/aeUAODL4eF

[Euretos @Euretos]

Unveiling Euretos' cell line selection workflow! It streamlines finding cell lines by gene expression, boosting efficiency in research, disease modeling, and drug discovery.
https://t.co/glqoIxNilQ

[Euretos @Euretos]

#TranslationalResearch in Heart Failure highlights the need to consider geographical and sex differences, driving personalized approaches. Understanding these variations is key to develop targeted strategies to improve outcomes across diverse populations. https://t.co/N7QCsMQCV9

[Euretos @Euretos]

The Euretos Platform powers translational research through better reuse of animal model data, reducing new experiments & enhancing efficiency. Dive into a vast collection of molecular and clinical databases for critical insights into target behavior across species.

[Euretos @Euretos]

Using AI to review literature is becoming popular. To avoid hallucination, our platform recognizes millions of concepts in disease and translational science giving you relevant publications and recommendations when doing a systematic literature review.
https://t.co/5kTXCzeyP9

[Euretos @Euretos]

This recent study evaluated cell surface biomarkers, selected via Euretos, a data-driven selection software, as potential targets for fluorescence-guided surgery in non-small cell lung cancers. Read more- https://t.co/uXMemuiCIa

[Euretos @Euretos]

Interesting read from McKinsey & Company👉In this time of rapid growth of AI in biopharma, attention today is on how to make the most of the opportunity to deliver value at scale by fully integrating AI approaches into scientific process changes. https://t.co/jzYCs7XEfy

[Euretos @Euretos]

Happy Holidays from the entire team at Euretos!

We wish you and your loved ones a healthy and prosperous New Year! 🎄🎆

[Euretos @Euretos]

One week to go for Biotechx 2022! Don't miss our presentation on 'The Euretos approach for target identification and indication selection' and the chance to grow your professional network. Save your spot today! https://t.co/EdQognpVOQ